Healthcare

All articles by Healthcare

Five things for pharma marketers to know: Wednesday, December 7, 2022
Five things for pharma marketers to know: Wednesday, December 7, 2022
Lecia Bushak
December 7, 2022
5:00 am

FDA gives Emergent Biosolutions priority review for OTC Narcan nasal spray; Gossamer’s experimental pulmonary arterial hypertension drug reaches its main goal with a smaller effect than expected; Neuralink faces federal probe, employee backlash to Elon Musk over animal tests.

Healthcare is on the ballot. Again.
Healthcare is on the ballot. Again.
MM+M Staff
December 5, 2022
10:00 am

Though overshadowed by alarming headlines about existential threats to democracy, healthcare proved a pivotal issue for midterm voters.

Five things for pharma marketers to know: Monday, December 5, 2022
Five things for pharma marketers to know: Monday, December 5, 2022
Jack O'Brien
December 5, 2022
5:00 am

WHO head says a new COVID variant of concern could emerge; The first year of the pandemic caused teens’ brains to age faster; Chinese cities announce further easing of COVID curbs, though police are still patrolling streets to stop protests.

Syneos Health: These are the 5 top health trends to look out for 2023
Syneos Health: These are the 5 top health trends to look out for 2023
Lecia Bushak
December 2, 2022
3:25 pm

Syneos Health identified several trends that will emerge in 2023, including a focus on improving retention in healthcare.

Five things for pharma marketers to know: Friday, December 2, 2022
Five things for pharma marketers to know: Friday, December 2, 2022
Jack O'Brien
December 2, 2022
5:30 am

Elon Musk says Neuralink aims to implant chips in humans within six months; U.S. sees surge in respiratory viruses for children under five; Pfizer invests more than $1.2 billion in Ireland.

Five things for pharma marketers to know: Thursday, December 1, 2022
Five things for pharma marketers to know: Thursday, December 1, 2022
Jack O'Brien
December 1, 2022
5:00 am

J&J sues Amgen over ulcerative colitis drug similar to Stelara; Researchers studying whether Paxlovid can treat long COVID; Horizon Therapeutics takeover interest fuels stock price.

Five things for pharma marketers to know: Wednesday, November 30, 2022
Five things for pharma marketers to know: Wednesday, November 30, 2022
Jack O'Brien
November 30, 2022
5:00 am

Guillain-Barré syndrome may have been sparked by RSV; Flu hospitalizations outpace COVID-19 hospitalizations; A common treatment for joint pain links to faster arthritis progression.

Bernie Sanders is set to lead Senate HELP committee: What this means for the pharma industry.
Bernie Sanders is set to lead Senate HELP committee: What this means for the pharma industry.
Lecia Bushak
November 29, 2022
1:44 pm

The leader of the progressive movement has voiced support for universal healthcare and further drug pricing regulations.

Five things for pharma marketers to know: Tuesday, November 29, 2022
Five things for pharma marketers to know: Tuesday, November 29, 2022
Lecia Bushak
November 29, 2022
5:00 am

FDA grants Sarepta accelerated review for its Duchenne gene therapy drug; Axsome Therapeutics announces positive results for Alzheimer’s agitation therapy; AstraZeneca signs a $402 million licensing deal with C4X Discovery.

Sanofi moves into new headquarters in Paris
Sanofi moves into new headquarters in Paris
Jack O'Brien
November 28, 2022
11:02 am

The French pharma giant said that each employee’s carbon footprint has been reduced by about 100% compared to the previous site.

  • From Our Partners